Bank of America’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.78M | Buy |
386,793
+42,499
| +12% | +$273K | ﹤0.01% | 3883 |
|
|
2025
Q4 | $1.94M | Sell |
344,294
-445,702
| -56% | -$2.42M | ﹤0.01% | 4092 |
|
|
2025
Q3 | $4.87M | Sell |
789,996
-34,604
| -4% | -$202K | ﹤0.01% | 4042 |
|
|
2025
Q2 | $4.02M | Buy |
824,600
+787,957
| +2,150% | +$2.79M | ﹤0.01% | 4123 |
|
|
2025
Q1 | $136K | Sell |
36,643
-46,828
| -56% | -$200K | ﹤0.01% | 6356 |
|
|
2024
Q4 | $334K | Buy |
83,471
+39,056
| +88% | +$214K | ﹤0.01% | 5823 |
|
|
2024
Q3 | $310K | Sell |
44,415
-27,944
| -39% | -$227K | ﹤0.01% | 5781 |
|
|
2024
Q2 | $410K | Buy |
72,359
+41,998
| +138% | +$376K | ﹤0.01% | 5465 |
|
|
2024
Q1 | $404K | Buy |
30,361
+26,402
| +667% | +$247K | ﹤0.01% | 5467 |
|
|
2023
Q4 | $24.3K | Buy |
3,959
+1,633
| +70% | +$5.22K | ﹤0.01% | 6753 |
|
|
2023
Q3 | $5.86K | Hold |
2,326
| – | – | ﹤0.01% | 6960 |
|
|
2023
Q2 | $12.2K | Hold |
2,326
| – | – | ﹤0.01% | 6816 |
|
|
2023
Q1 | $11K | Sell |
2,326
-397
| -15% | -$2.39K | ﹤0.01% | 6895 |
|
|
2022
Q4 | $14.6K | Buy |
2,723
+390
| +17% | +$2.56K | ﹤0.01% | 6833 |
|
|
2022
Q3 | $17K | Sell |
2,333
-1,021
| -30% | -$10.3K | ﹤0.01% | 7095 |
|
|
2022
Q2 | $31K | Sell |
3,354
-125
| -4% | -$1.3K | ﹤0.01% | 7039 |
|
|
2022
Q1 | $63K | Sell |
3,479
-999
| -22% | -$17.6K | ﹤0.01% | 7081 |
|
|
2021
Q4 | $118K | Sell |
4,478
-3,879
| -46% | -$119K | ﹤0.01% | 6806 |
|
|
2021
Q3 | $299K | Buy |
8,357
+5,172
| +162% | +$220K | ﹤0.01% | 6009 |
|
|
2021
Q2 | $175K | Sell |
3,185
-2,330
| -42% | -$154K | ﹤0.01% | 6184 |
|
|
2021
Q1 | $458K | Sell |
5,515
-3,055
| -36% | -$338K | ﹤0.01% | 5439 |
|
|
2020
Q4 | $974K | Buy |
8,570
+2,347
| +38% | +$148K | ﹤0.01% | 4527 |
|
|
2020
Q3 | $189K | Buy |
6,223
+5,440
| +695% | +$208K | ﹤0.01% | 5324 |
|
|
2020
Q2 | $35K | Buy |
783
+151
| +24% | +$6.27K | ﹤0.01% | 6115 |
|
|
2020
Q1 | $23K | Sell |
632
-2,150
| -77% | -$106K | ﹤0.01% | 6139 |
|
|
2019
Q4 | $186K | Sell |
2,782
-1,246
| -31% | -$138K | ﹤0.01% | 5678 |
|
|
2019
Q3 | $624K | Buy |
4,028
+2,893
| +255% | +$327K | ﹤0.01% | 4925 |
|
|
2019
Q2 | $97K | Buy |
1,135
+591
| +109% | +$64.5K | ﹤0.01% | 6031 |
|
|
2019
Q1 | $75K | Buy |
544
+361
| +197% | +$90.4K | ﹤0.01% | 6022 |
|
|
2018
Q4 | $73K | Sell |
183
-22
| -11% | -$10.3K | ﹤0.01% | 6069 |
|
|
2018
Q3 | $145K | Buy |
205
+74
| +56% | +$46.5K | ﹤0.01% | 5669 |
|
|
2018
Q2 | $70K | Buy |
131
+74
| +130% | +$22.8K | ﹤0.01% | 5975 |
|
|
2018
Q1 | $6K | Buy |
+57
| New | +$19.2K | ﹤0.01% | 6736 |
|
Other funds holding SLDB
PA
BCLSI
RCM
SL
VPC
DTC
AC
Bank of America's SLDB Position: Q1 2026 in Review
Bank of America increased its Solid Biosciences (SLDB) stake by 12% in Q1 2026, buying an estimated $273K and bringing the position to 386,793 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3883.
Bank of America first reported a position in SLDB in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.87M in Q3 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.
- Bank of America held 386,793 shares of Solid Biosciences worth $2.78M as of Q1 2026.
- Bank of America bought 42,499 Solid Biosciences shares in Q1 2026, an estimated $273K.
- Solid Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3883 holding.
- Bank of America first reported a position in Solid Biosciences in Q1 2018 and has held it in 33 quarters since.
- Bank of America's Solid Biosciences position peaked at $4.87M in Q3 2025.
- 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.